Hanna Nohynek
Datos Biográficos
| ID | 5082410 |
|---|---|
| NOMBRE | Hanna Nohynek |
| NOMBRES | Hanna |
| APELLIDO | Nohynek |
| FIRMA | NOHYNEK H |
| AFILIACIONES | Finnish Institute for Health and Welfare |
| ORCID | 0000-0001-8220-3669 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAS | 1 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2021 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2023 |
| ÍNDICE H | 1 |
Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe
Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under the umbrella of the Innovative Medicines Initiative (IMI) and conducted IVE studies from its pilot season in 2017-2018 to its final season in 2021-20…
Nationwide health, socio-economic and genetic predictors of Covid-19 vaccination status in Finland
Understanding factors associated with COVID-19 vaccination can highlight issues in public health systems. Using machine learning, we considered the effects of 2,890 health, socio-economic and demographic factors in the entire Finnish population aged 30–80 and genome-wide information from 273,765 individuals. The strongest predictors of vaccination status were labour income and medication purchase history. Mental health conditions and having unvac…
Novel vaccine safety issues and areas that would benefit from further research
Vaccine licensure requires a very high safety standard and vaccines routinely used are very safe. Vaccine safety monitoring prelicensure and postlicensure enables continual assessment to ensure the benefits outweigh the risks and, when safety problems arise, they are quickly identified, characterised and further problems prevented when possible. We review five vaccine safety case studies: (1) dengue vaccine and enhanced dengue disease, (2) pandem…
Nationwide health, socio-economic and genetic predictors of Covid-19 vaccination status in Finland
Understanding factors associated with COVID-19 vaccination can highlight issues in public health systems. Using machine learning, we considered the effects of 2,890 health, socio-economic and demographic factors in the entire Finnish population aged 30–80 and genome-wide information from 273,765 individuals. The strongest predictors of vaccination status were labour income and medication purchase history. Mental health conditions and having unvac…
Novel vaccine safety issues and areas that would benefit from further research
Vaccine licensure requires a very high safety standard and vaccines routinely used are very safe. Vaccine safety monitoring prelicensure and postlicensure enables continual assessment to ensure the benefits outweigh the risks and, when safety problems arise, they are quickly identified, characterised and further problems prevented when possible. We review five vaccine safety case studies: (1) dengue vaccine and enhanced dengue disease, (2) pandem…
Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe
Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under the umbrella of the Innovative Medicines Initiative (IMI) and conducted IVE studies from its pilot season in 2017-2018 to its final season in 2021-20…
Nationwide health, socio-economic and genetic predictors of Covid-19 vaccination status in Finland
Understanding factors associated with COVID-19 vaccination can highlight issues in public health systems. Using machine learning, we considered the effects of 2,890 health, socio-economic and demographic factors in the entire Finnish population aged 30–80 and genome-wide information from 273,765 individuals. The strongest predictors of vaccination status were labour income and medication purchase history. Mental health conditions and having unvac…
Medicine (3 obras) · Vaccination (3 obras) · Demography (2 obras) · Environmental health (2 obras) · Immunology (2 obras) · Influenza Virus Research Studies (2 obras) · Nursing (2 obras) · SARS-CoV-2 and COVID-19 Research (2 obras) · Vaccine Coverage and Hesitancy (2 obras) · 2019-20 coronavirus outbreak (1 obras)